Trinity Biotech Receives $7 Million Investment, Achieves Nasdaq Compliance

Trinity Biotech (TRIB) has secured a $7.0 million investment from Perceptive Advisors, a move that enabled the company to regain compliance with Nasdaq's minimum bid price requirement. This funding stabilizes Trinity Biotech's capital base and mitigates a significant near-term risk of delisting, ensuring its continued presence on the exchange.